- Advertisement -

Find a job

Subscribe for free

All things Pharma

Almirall and Happify Health psoriasis digital platform solution

Almirall and Happify Health have entered into a strategic partnership to develop a version of its digital platform specifically for people with psoriasis in the UK, Spain, Italy and France.

It is estimated that 20-30% of patients with moderate to severe psoriasis suffer from mental health issues such as anxiety and depression[i]. Happify Health, through evidence-based and clinically validated platforms, delivers mental health solutions targeted to patients with chronic diseases.

The Almirall partnership with Happify Health will focus on a solution called CLARO targeted to addressing the mental health concerns of psoriasis patients. The goal of the CLARO program is to create a solution/service to help psoriasis patients improve their well-being when living with a chronic disease providing a meaningful, dynamic and fun user experience. CLARO will be delivered through the Almirall patient support program.

Francesca Domenech Wuttke, Chief Digital Officer at Almirall said: “We are so pleased to be joining Happify Health on their mission to improve the lives of patients with chronic conditions. This partnership will allow us to provide patients with psoriasis a solution based on a clinically validated positive psychology platform. We selected Happify as our partner as they have already demonstrated a positive impact on the mental health of patients with chronic conditions, including psoriasis, in published research.”

Chris Wasden, Head of Digital Therapeutics at Happify Health said: “Since mental health events act as stressors that can trigger psoriasis flare ups, Happify is excited to work with a European leader like Almirall in this condition to address the mental and physical health symptoms of these patients. Our digital therapeutic solution acts as a complement to Almirall’s commitment to psoriasis patients to empower people with psoriasis to live full lives through meaningful behavior change. Together, we can help psoriasis patients, one patient at a time, and at scale.”

Reference

[i] H.L. Richards, D.G. Fortune, C.E. Griffiths, C.J. Main The contribution of perceptions of stigmatisation to disability in patients with psoriasis.

- Advertisement -
Emma Cooper
Emma is Digital Editor at Pf.

MORE FROM AUTHOR

- Advertisement -

LATEST POSTS

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription